Dendreon Corp. (NASDAQ:DNDN) will release earnings next Tuesday, August 7, after the close. The volatility in shares has dried up considerably as shares have only traded above $8.00 or below $7.00 for part of…
Not a good quarter for Pfizer (PFE). Second quarter revenue fell 6% to $11.1 billion. Net income was down 48% to $1.3 billion. The loss of U.S. exclusivity for Zoloft and Norvasc hurt earnings…
There was a bit of an unusual message this morning, and that was an advertisement about Dendreon’s (NASDAQ:DNDN) Provenge in the Sunday edition of The Washington Post. Yet it apparently isn’t from the company…
It appears that Dendreon (NASDAQ:DNDN) may be an SEC target now, or at least it is going to get the pleasure of dealing with the SEC for a while. The New York regional office…
Dendreon (DNDN-NASDAQ) is trading up almost another 2% pre-market after Tuesday options activity had shares up $0.47 to close at $7.70 per share. The shares actually hit as high as $8.30 on Tuesday, which…
CryoCor Inc. (CRYO-NASDAQ) is trading up almost 100% in early trading today. Last night the company announced that an FDA Advisory Panel had recommended backing the company’s pre-market approval application for the company’s treatment…
Stock Tickers: DNDN, NFLD, NSTK, ADLR, ALTH, COLY, CEGE, NUVO Many of the recent biotech implosions are always interesting to see if short sellers are getting out of the way or adding pressure. Out…
Nuvelo, Inc. (NUVO-NASDAQ) dropped the bomb today with the announcement that it will resume development of alfimeprase, its lead investigational product candidate for the potential treatment of multiple blood clot-related disorders such as acute…
Stock Tickers: SFE, CLRT, CMGI, ICGE Late last week, 24/7 Wall St. got the chance to interview Peter J. Boni, President & CEO of Safeguard Scientifics, Inc. (SFE-NYSE). Mr. Boni has been President &…
As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag. GlaxoSmithkline (GSK) saw the lagest increase, but its short…
Orexigen Therapeutics, Inc. (OREX-NASDAQ), a biopharmaceutical with an initial focus on obesity, has announced that data presented today at the American Diabetes Association 67th Scientific Sessions in Chicago from a sub-study of its Phase…
Stock Tickers: STEM, GERN, ASTM Senator Obama has issued a statement regarding President Bush’s veto of the Embryonic Stem Cell Bill: Senator Obama noted: "By vetoing funding for stem cell research once again, the…
Shares of microcap biotech Coley Pharmaceutical Group (COLY-NASDAQ) saw shares get pounded late on Wednesday afternoon. Right before 2:00 PM EST, the company announced that its partner Pfizer (PFE-NYSE) had discontinued and exited its…
Allos Therapeutics, Inc. (ALTH-NASDAQ) is indicated down almost 20% in thin pre-market trading after it announced that top line results from ENRICH, the Company’s pivotal Phase III study of EFAPROXYN plus whole brain radiation…
A new inhaled-molecule company named MAP Pharmaceuticals, Inc. has filed for an IPO. Underwriters are listed as Merrill lynch, Morgan Stanley, and Deutsche Bank. It has a proposed stock ticker of "MAPP" on NASDAQ.…